Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion
1 other identifier
observational
750
1 country
5
Brief Summary
The purpose of this study is to identify changes in salivary micro ribonucleic acid (miRNA) levels that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2020
CompletedFirst Posted
Study publicly available on registry
October 9, 2020
CompletedStudy Start
First participant enrolled
January 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedMarch 11, 2026
February 1, 2026
4.8 years
September 24, 2020
March 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Presence or absence of persistent post-concussive symptoms (PPCS) 30 days after injury
PPCS will be defined by persistence of at least 3 symptoms on day 30, compared with pre-injury state, which will be determined from pre-injury symptoms reported at enrollment using the Post-Concussion Symptom Inventory (PCSI). PCSI is a self reported survey that focus on symptoms in the cognitive, emotional, sleep, and physical domains. This form is called the "Sport Concussion Assessment Tool- 5th Edition" and symptoms are scored from 0 to 6 with 0 being no symptom and 6 being severe. A high score is indicative of a subject experiencing the worst they have experienced this symptom.
30 days after injury
Presence or absence of concussion recovery 30 days after injury
Defined as a score of 0 (no difference) on item 22 of the Post-Concussion Symptom Inventory (PCSI); "To what degree do you feel 'differently' than before your injury?" This patient-oriented outcome measure relies on the individual's experience of symptoms to define recovery.PCSI is a self reported survey that focus on symptoms in the cognitive, emotional, sleep, and physical domains. This form is called the "Sport Concussion Assessment Tool- 5th Edition" and symptoms are scored from 0 to 6 with 0 being no symptom and 6 being severe.
30 days after injury
Secondary Outcomes (3)
Concussion symptom burden and severity
Within 48 hours of injury, 7 days post-injury, and 30 days post-injury
Orientation, immediate memory, concentration, and delayed recall performance
Within 48 hours of injury
Balance performance
Within 48 hours of injury
Eligibility Criteria
Children 13-18 years with mild traumatic brain injury
You may qualify if:
- Presence of mTBI: defined by criteria from the Berlin Consensus Statement and WHO. Assessment for mTBI status be performed by a licensed clinician per the 2018 CDC guidelines.
- Age at enrollment: 13-18 years of age (inclusive).
You may not qualify if:
- \> 48 hours after initial mTBI
- Glasgow Coma Scale score of 13 or less
- Previous moderate-to-severe TBI requiring overnight hospitalization
- Unresolved symptoms from previous concussion, or any concussion within the last 3 months
- Abbreviated Injury Scale (AIS) score \> 3 (to reduce confounding from poly-trauma)
- Psychiatric illness requiring previous hospitalization;
- Neurological condition (e.g. epilepsy, hydrocephalus) or abnormality on neuroimaging (if performed)
- Intellectual disability that prevents ability to provide informed assent
- Pregnancy
- Active substance use/dependence
- Previous neurosurgery
- Non-fluency in English
- Upper respiratory infection
- Periodontal infection
- Injury to the oropharynx
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Boston Children's Hosptial
Boston, Massachusetts, 02115, United States
Weill Cornell Medicine/ New York Presbyterian Hospital
New York, New York, 10021, United States
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steve Hicks, MD, PhD
Penn State University, College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Pediatrics
Study Record Dates
First Submitted
September 24, 2020
First Posted
October 9, 2020
Study Start
January 18, 2021
Primary Completion
November 1, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
March 11, 2026
Record last verified: 2026-02